CLINICAL AND EXPERIMENTAL RATIONALE FOR THE FEASIBILITY OF USING A COMBINED FIBRIN–BONE SCAFFOLD WITH A PRONOUNCED LOCAL ANTIMICROBIAL EFFECT

Yevchuk Yu. I., Pantus A. V.

CLINICAL AND EXPERIMENTAL RATIONALE FOR THE FEASIBILITY OF USING A COMBINED FIBRIN–BONE SCAFFOLD WITH A PRONOUNCED LOCAL ANTIMICROBIAL EFFECT


Show/Download

About the author:

Yevchuk Yu. I., Pantus A. V.

Heading:

DENTISTRY

Type of article:

Scientific article

Annotation:

The article discusses the effectiveness of a newly developed method for improving the efficiency of bone augmentation in the replacement of bone tissue defects. The aim of this study was to determine the efficacy of restoring jaw- bone defects using an allogeneic–autologous material obtained by the simultaneous centrifugation of demineralised bone substitute granules and the patient’s venous blood. For the clinical study, 90 patients aged 20 to 40 years with radicular cysts of the jaws were selected. All patients were divided into Groups I, II and III, who underwent cystectomy followed by bone grafting. In Group I, a scaffold was used that had been prepared according to the protocol we developed. Microbiological analysis revealed a more pronounced cumulative effect of lincomycin at low concentrations in the pressed plasma fraction (18.75 mg/mL) and in the fibrin matrix (9.4 mg/mL). The results of postoperative clinical and radiological examinations confirmed the effectiveness of the technique we developed. This was evidenced by the high proportion of patients in Group I (83.3%) who achieved complete restoration of the bone defect, which correlated with bone tissue density values ranging from 575.45±20.55 to 636.90±16.64 HU, corresponding to intact bone. In contrast, in Groups II and III, only 16 patients (53.3%) and 13 patients (43.3%), respectively, demonstrated complete restoration of bone tissue. Clinical and radiological analysis thus confirmed the effectiveness of the method we developed, as indicated by positive outcomes in the form of complete bone tissue restoration in 83.3% of patients in Group I, compared with 53.3% in Group II and 43.3% in Group III.

Tags:

antimicrobial effect, bone plastic material, bone plastic surgery, bone tissue, bone tissue regeneration, microbiological study, radicular cyst

Bibliography:

  1. Korniyenko MM. Vedennya rannoho pislyaoperatsiynoho periodu pislya tsystektomiyi iz zastosuvannyam preparatu na osnovi benzydaminu hidrokhlorydu. Novyny stomatolohiyi. 2015;2:45-8. [in Ukrainian].
  2. Lytvynets-Holutyak UYe. Doslidzhennya makro- ta mikroelementnoho statusu u khvorykh na odontohenni kysty. Aktualni problemy suchasnoyi medytsyny: Visnyk Ukrayinskoyi medychnoyi stomatolohichnoyi akademiyi. 2013;3(43):47-50. [in Ukrainian].
  3. Ruzin GP, Tkachenko OV. Klinicheskiye proyavleniya toksicheskogo osteomiyelita v zavisimosti ot davnosti upotrebleniya narkotika. Ukrainskiy stomatologíchniy almanakh. 2015; 1: 47-52. [in Ukrainian].
  4. Avetikov DS, Stavytskyy SA, Lokes KP, Yatsenko IV. Otsinka efektyvnosti auhmentatsiyi alveolyarnoho hrebnya na etapi pidhotovky do dentalnoyi implantatsiyi. Visnyk problem biolohiyi i medytsyny. 2016;1(131):240-2. [in Ukrainian].
  5. Pavlenko AV, Dmitriyeva EA, Luzin VI. Gistologicheskoye stroyeniye regenerata pri zapolnenii kostnogo defekta materialami easygraft i trikaltsiyfosfatom. Morfologiya. 2011;5(2):49-54. [in Ukrainian].
  6. Pavlenko OV, Dmytriyeva YeO. Morfolohichni osnovy vyboru kistkovoplastychnykh materialiv u parodontolohiyi. Morfolohiya. 2011;5(1):5- 12. [in Ukrainian].
  7. Berwig KH, Baldasso C, Dettmer A. Production and characterization of poly(3-hydroxybutyrate) generated by Alcaligenes latus using lactose and whey after acid protein precipitation process. Bioresour. Technol. 2016;218:31-7.
  8. Hapach LA, VanderBurgh JA, Miller JP, Reinhart-King CA. Manipulation of in vitro collagen matrix architecture for scaffolds of improved physiological relevance. Physical Biology. 2015;12(6):061002. DOI: 10.1088/1478-3975/12/6/061002.
  9. Pantus AV, Rozhko MM, Paliychuk VI, Kovalchuk NY, Melnyk NS. Microstructure of biopolymer micro-fibrous scaffold and its influence on the ability to retain medicines and tissue regeneration. Georgian medical news. 2023;3(336):37-44.
  10. Crisci A, Lombardi D, Serra E, Lombardi G, Cardillo F, Crisci M. Standardized protocol proposed for clinical use of L-PRF and the use of L-PRF Wound Box®. J Unexplored Med Data. 2017;2:77-87. DOI: 10.20517/2572-8180.2017.17.
  11. Kubesch A, Barbeck M, Al-Maawi S, Orlowska A, Booms P, Sader R, et al. A low-speed centrifugation concept leads to cell accumulation and vascularization of solid platelet-rich fibrin: An experimental study in vivo. Platelets. 2019;30(3):329-340. DOI: 10.1080/09537104.2018.1445835.
  12. Lee HM, Shen EC, Shen JT, Fu E, Chiu HC, Hsia YJ. Tensile strength, growth factor content and proliferation activities for two platelet concentrates of platelet-rich fibrin and concentrated growth factor. J. Dent. Sci. 2020;15(2):141-146. DOI: 10.1016/j.jds.2020.03.011.
  13. Li W, Sigley J, Pieters M, Helms C, Nagaswami C, Weisel JW, et al. Fibrin Fiber Stiffness Is Strongly Affected by Fiber Diameter, but Not by Fibrinogen Glycation. Biophys. J. 2016;110(6):1400-1410. DOI: 10.1016/j.bpj.2016.02.021.
  14. McLellan J, Plevin S. Temporal release of growth factors from platelet- rich fibrin (PRF) and platelet-rich plasma (PRP) in the horse: a comparative in vitro analysis. International Journal of Applied Research in Veterinary Medicine. 2014;12(1):48-57.
  15. Caymaz G, Uyanik O. Comparison of the effect of advanced platelet-rich fibrin and leukocyte- and platelet-rich fibrin on outcomes after removal of impacted mandibular third molar: A randomized split-mouth study. Niger. J. Clin. Pract. 2019;22(4):546-552. DOI: 10.4103/njcp.njcp_473_18.
  16. Canellas JVDS, Medeiros PJD, Figueredo CMDS, Fischer RG, Ritto FG. Platelet-richfibrin in oral surgical procedures: A systematic review and meta-analysis. Int. J. Oral Maxillofac. Surg. 2019;48(3):395-414. DOI: 10.1016/j.ijom.2018.07.007.
  17. Caruana A, Savina D, Macedo JP, Soares SC. From Platelet- Rich Plasma to Advanced Platelet-Rich Fibrin: Biological Achievements and Clinical Advances in Modern Surgery. Eur. J. Dent. 2019;13(2):280-286. DOI: 10.1055/s-0039-1696585.
  18. Crisci A, Manfredi S, Crisci M. Fibrinrich in Leukocyte- Platelets (L-PRF) and Injectable Fibrin Rich Platelets (I-PRF), two opportunity in regenerative surgery: Review of the sciences and literature. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS). 2019;18:66-79.
  19. Choukroun J, Ghanaati S. Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: The first introduction to the low speed centrifugation concept. Eur. J. Trauma Emerg. Surg. 2018;44(1):87-95. DOI: 10.1007/s00068-017-0767-9.
  20. Siawasch SAM, Andrade C, Castro AB, Teughels W, Temmerman A, Quirynen M. Impact of local and systemic antimicrobials on leukocyte- and platelet rich fibrin: an in vitro study. Scientific Reports. 2022;12(1):2710. DOI: 10.1038/s41598-022-06473-4.
  21. Crisci A, Barillaro MC, Lepore G, Cardillo F. L-PRF Membrane (FibrinRich in Platelets and Leukocytes) and Its Derivatives (A-PRF, i- PRF) are Help ful as a Basis of Stem Cells in Regenerative Injury Treatment: Trial Work on the Horse. International Blood Research & Reviews. 2019;10(2):1-14.
  22. Crisci A, Benincasa G, Crisci M, Crisci F. Leukocyte Platelet-Rich Fibrin (L-PRF), a new biomembrane useful in tissue repair: basic science and literature review. Biointerface Research in Applied Chemistry. 2018;8(5):3635-43.
  23. Kim BJ, Kwon TK, Baek HS, Hwang DS, Kim CH, Chung IK, et al. A comparative study of the effectiveness of sinus bone grafting with recombinant human bone morphogenetic protein 2-coated tricalcium phosphate and platelet-rich fibrin-mixed tricalcium phosphate in rabbits. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113(5):583-92. DOI: 10.1016/j.tripleo.2011.04.029.
  24. De Almeida NCPM, Dos Santos NBM, Completo AMG, De Oliveira FGV. Tensile strength assay comparing the resistance between two different autologous platelet concentrates (leucocyte-platelet rich fibrin versus advanced- plateletrichfibrin): A pilotstudy. Int. J. Implant Dent. 2021;7(1):1. DOI: 10.1186/s40729-020-00284-w.
  25. El Bagdadi K, Kubesch A, Yu X, Al-Maawi S, Orlowska A, Dias A, et al. Reduction of relative centrifugal forces increases growth factor release within solid platelet- rich fibrin (PRF)-based matrices: a proof of concept of LSCC (low speed centrifugation concept). European Journal of Trauma and Emergency Surgery. 2019;45(3):467-79.
  26. Polak D, Clemer-Shamai N, Shapira L. Incorporating antibiotics into platelet-rich fibrin: a novel antibiotics slow-release biological device. J Clin Periodontol. 2019;46:241-247. DOI: 10.1111/jcpe.13063.
  27. Wang S, Li Y, Li S, Yang J, Tang R, Li X, et al. Platelet-rich plasma loaded with antibiotics as an affiliated treatment for infected bone defect by combining wound healing property and antibacterial activity. Platelets. 2021;32(4):479-491. DOI: 10.1080/09537104.2020.1759792.
  28. Whitman WB, DeVos P, Dedysh S. Bergey’s manual of systematics of Archaea and Bacteria. Hoboken, New Jersey: John Wiley & Sons; 2015.
  29. Salam MA, Al-Amin MY, Pawar JS, Akhter N, Lucy IB. Conventional methods and future trends in antimicrobial susceptibility testing. Saudi J Biol Sci. 2023;30(3):103582. DOI: 10.1016/j.sjbs.2023.103582.
  30. Belanger CR, Hancock REW. Testing physiologically relevant conditions in minimal inhibitory concentration assays. Nat Protoc. 2021;16(8):3761-3774. DOI: 10.1038/s41596-021-00572-8.

Publication of the article:

«Bulletin of problems biology and medicine», 2025 Issue 3,178, 526-540 pages, index UDC 616.314-71+616.314-089+616.314-007

DOI:

10.29254/2077-4214-2025-3-178-526-540

Was this article helpful?

Leave a Reply

Your email address will not be published. Required fields are marked *


The reCAPTCHA verification period has expired. Please reload the page.